1.94 FDA panel says Vertex/CRISPR to assess safety risks of gene therapy in follow-up study

<< vissza

FDA panel says Vertex/CRISPR to assess safety risks of gene therapy in follow-up study
Dátum: 2023-10-31 [news.yahoo.com]

A TELJES HÍR ELOLVASÁSA >>
×